Add Company
Join Now

Spepharm Holding BV Revenue and Competitors

License our Company Data API

Amsterdam, Netherlands

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Spepharm Holding BV's estimated annual revenue is currently $237.8M per year.(i)
  • Spepharm Holding BV's estimated revenue per employee is $201,000

Employee Data

  • Spepharm Holding BV has 1183 Employees.(i)
  • Spepharm Holding BV grew their employee count by -1% last year.

Spepharm Holding BV's People

NameTitleEmail/Phone
1
Chief Commercial OfficerReveal Email/Phone
2
Head EngineeringReveal Email/Phone
3
Quality Assurance OfficerReveal Email/Phone
4
Head Commercial IberiaReveal Email/Phone
5
VP Commercial Operations Consumer HealthcareReveal Email/Phone
6
HR OfficerReveal Email/Phone
7
Finance Director - Consumer HealthcareReveal Email/Phone
8
Senior Director, Patient Engagement, Government Affairs & Public PolicyReveal Email/Phone
9
Career and Succession DirectorReveal Email/Phone
10
Director ProcurementReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$13.9M69-1%N/AN/A
#2
$43.8M218-13%N/AN/A
#3
$51.9M2584%N/AN/A
#4
$32.2M1600%N/AN/A
#5
$237.8M1183-1%N/AN/A
#6
$3.8M1946%N/AN/A
#7
$237.8M1183-1%N/AN/A
#8
$20.1M100-31%N/AN/A
#9
$75M373-8%N/AN/A
#10
$2M1025%N/AN/A
Add Company

What Is Spepharm Holding BV?

Norgine is a leading European specialist pharmaceutical company that has been bringing transformative medicines to patients for over a century. Our commitment to transforming people's lives drives everything we do and our European experience, fully integrated infrastructure and exceptional partnership approach enables us to quickly apply creative solutions to bring life-changing medicines to patients that they may not otherwise be able to access. Norgine is proud to have helped 22 million patients around the world in 2019 and generated €419 million in net product sales, a growth of 6% over 2018. Norgine has a direct presence in 12 European countries, as well as Australia and New Zealand. We also have a strong global network of partnerships in non-Norgine markets. We are a flexible and fully integrated pharmaceutical business, with manufacturing (Hengoed, Wales and Dreux, France), third party supply networks and significant product development capabilities, in addition to our sales and marketing infrastructure. This enables us to acquire, develop and commercialise specialist and innovative products that make a real difference to the lives of patients around the world. In 2012, Norgine established Norgine Ventures, a complementary business which supports innovative healthcare companies through the provision of debt-like financing in Europe and the US. For more information, please visit www.norgineventures.com.

keywords:N/A

N/A

Total Funding

1183

Number of Employees

$237.8M

Revenue (est)

-1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$237.8M1183-1%N/A
#2
$35M121471%N/A
#3
$259.4M1278-4%N/A
#4
$15M12857%N/A
#5
$411.8M14353%N/A